AngioDynamics

Pancreatic cancer accounts for about 3% of all cancers in the United States, with an average lifetime risk affecting 1 in 56 men and about 1 in 60 women. Early diagnosis is the key to allowing for more treatment options. At AngioDynamics, we are committed to raising awareness of Pancreatic Cancer and supporting clinical trials to develop new and effective treatment pathways. #PancreaticCancerAwareness #EarlyDetectionSavesLives #PurpleRibbon #PancreaticCancerResearch Reference: https://lnkd.in/gRaDxbQE

🎉 We’re excited to announce that Linda Upchurch, Vice President, Global Healthcare Economics, will be taking part in an insightful panel discussion on “Reimbursement, Rates & Revenue” at the LifeSciencesNY annual conference, Together ‘24. Her expertise and dedication to advancing healthcare innovation make her a valuable voice in navigating today’s complex reimbursement landscape. Join us in celebrating Linda’s contributions and insights as she represents our team on this important topic! 🌟 #TeamSpotlight #Together24 #HealthcareInnovation #Reimbursement

🚀 Exciting News from AngioDynamics! 🚀 We’re thrilled to announce that the American Medical Association's CPT® Editorial Panel has granted Category I CPT® codes for Irreversible Electroporation (IRE) in treating tumors in the prostate or liver! This significant milestone enhances market access to the NanoKnife System and facilitates reimbursement for healthcare providers performing IRE ablation procedures. Starting January 1, 2026, these new codes will empower providers to offer patients this innovative and minimally invasive treatment option that preserves surrounding structures and tissue, expanding access and care across the country. Jim Clemmer, President and CEO, highlighted the achievement as a testament to our commitment to innovative patient care. Learn more about the CPT Code: https://lnkd.in/de5_m_Np Explore more about the NanoKnife System at nanoknife.com Contact Us: https://lnkd.in/gbXwCYKW Risk Info: https://lnkd.in/gFNG_pA *In the United States, the NanoKnife System has received a 510(k) clearance by the Food and Drug Administration for the surgical ablation of soft tissue. The NanoKnife System has not been cleared for the treatment or therapy of a specific disease or condition.

Today is #WorldThrombosisDay. On this day we recognize those affected by Thrombosis. Our team is committed to improving lives affected by one of the world’s most deadly diseases. Learn more at: www.worldthrombosisday.org. Risk Info: https://lnkd.in/gZpTgEYv #WTD2024 #BioFlo

On #WorldThrombosisDay, we recognize those affected by the overlooked and misunderstood condition of thrombosis – the formation of a blood clot in a blood vessel. This condition occurs in people of all ages, races, and ethnicities. Knowing the signs, symptoms, and types of thrombosis can help you and others understand if they are at higher risk. Learn more at https://lnkd.in/eA-4h9B5. At AngioDynamics, our team is committed to improving lives affected by one of the world’s most deadly diseases. Will you join us? #WTD24 #PERT #Thrombus #AlphaVac #Bloodclot

Our Interventional Devices Team is live at #ALVS24 in Chicago! We are at booth #219 - stop by to learn all that our EVLT portfolio offers.

#AVLS24 countdown! Don’t miss us in Chicago, IL on October 10th-13th! Stop by booth #219 to learn about our EVLT Portfolio. #AVLS #EVLT

The AngioDynamics VenaCure PVAK procedure kit enables clinicians to deliver laser fiber directly through a 21-gauge needle, providing precision energy delivery. #VasularDiseaseAwareness #VascularDiseaseAwarenessMonth24 Risk Info: https://lnkd.in/gFNG_pA

The AngioDynamics team is excited to be in Washington D.C. for the joint meeting between #TheFocalTherapySociety and #SocietyofUrologicRoboticSurgeons We are starting the day off strong with the The NanoKnife System’s Masterclass! A big thank you to our amazing faculty, medical education team, and the physicians who took time to learn more about this exciting technology! Brianne Cichoski & Margeaux Hayden #medicaleducation #urology #FTS #SURS #medtech #innovation